Información del producto
BI8626 is a covalent inhibitor of the ubiquitin ligases that are involved in the proteasome pathway. It has been shown to have anti-cancer and anti-inflammatory properties. BI8626 is a small molecule that targets e3 ubiquitin ligases, which are enzymes that regulate protein degradation by ubiquitination. Low expression of these enzymes has been observed in cancer cells and inflammatory diseases. The mechanism of action for BI8626 is not well understood but it is thought that this drug inhibits the proteasome pathway, leading to reduced inflammation and tumor growth.
Propiedades químicas
Consulta técnica sobre: 3D-AAD03675 BI8626
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
